China predicted to become world's second largest OTC medicine market in 2010
Friday,October 30,2009 Posted: 00:15 BJT(1615 GMT)
  From:Chinaview    Article type:Reproduced

China will become the world's second largest market of non-prescriptive medicine, or "over the counter"(OTC) medicine in 2010, a senior executive with a European pharmaceutical giant said Saturday.

Olivier Charmeil, Sanofi-Aventis' senior vice president for pharmaceutical operations in Asia/Pacific and Japan predicted Saturday made the prediction here.

In 2008, the scale of OTC medicine market in China hit 70 billion yuan (about 10 billion U.S. dollars), with Vitamin and mineral products taking the lion's share.

Sanofi-Aventis China announced Saturday the decision of building a joint venture to focus on vitamin and mineral medicines with China's Minsheng Pharmaceutical Group Co., Ltd.

The move was a strategic one for Sanofi-Aventis to enter the Chinese OTC medicine market, said Charmeil.

The pharmaceutical giant will control the majority of the shares of the joint venture pending the signing of an agreement.

(Source: English Site of Nigeria)

Big Medium-sized Small】 【Print】 【Transmit】 【E-mail

All articles marked with "Article type: Original" posted on the website of the Ministry of Commerce and its sub-sites are copyrighted by this Website and its sub-sites. Any reproduction or use by any other websites, media or individuals must be attached with a clear indication of "Source: Ministry of Commerce Website".

All articles posted on this website or its sub-sites marked with "Article type: reproduced" or "Article type: translated" and "Article type: redistributed" come from other media, and are provided solely for the user's information, which does not mean this Website or its sub-sites endorse the ideas thereof or assume any legal liability or responsibility for their authenticity. Any other media, websites or individuals must maintain the source of information indication on this Website or its sub-sites when using the information, and shall assume legal liability for the use.

  Release Comment: Pen Name: View Comment